JPWO2019161494A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019161494A5 JPWO2019161494A5 JP2020566867A JP2020566867A JPWO2019161494A5 JP WO2019161494 A5 JPWO2019161494 A5 JP WO2019161494A5 JP 2020566867 A JP2020566867 A JP 2020566867A JP 2020566867 A JP2020566867 A JP 2020566867A JP WO2019161494 A5 JPWO2019161494 A5 JP WO2019161494A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- cells
- formula
- stem
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862632733P | 2018-02-20 | 2018-02-20 | |
| US62/632,733 | 2018-02-20 | ||
| PCT/CA2019/050208 WO2019161494A1 (en) | 2018-02-20 | 2019-02-20 | Expansion of nk and dc cells in vivo mediating immune response |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021521262A JP2021521262A (ja) | 2021-08-26 |
| JPWO2019161494A5 true JPWO2019161494A5 (https=) | 2022-02-24 |
| JP2021521262A5 JP2021521262A5 (https=) | 2022-02-24 |
| JP7467358B2 JP7467358B2 (ja) | 2024-04-15 |
Family
ID=67687479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566867A Active JP7467358B2 (ja) | 2018-02-20 | 2019-02-20 | 免疫応答を媒介するｉｎ ｖｉｖｏでのＮＫ細胞およびＤＣ細胞の拡大 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12011460B2 (https=) |
| EP (1) | EP3755355A4 (https=) |
| JP (1) | JP7467358B2 (https=) |
| CN (1) | CN112135618A (https=) |
| CA (1) | CA3091865A1 (https=) |
| WO (1) | WO2019161494A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109212187B (zh) * | 2018-09-06 | 2022-01-11 | 东华大学 | 一种检测多环芳烃的类酶联免疫试剂盒及其应用 |
| CN112851678B (zh) * | 2019-11-28 | 2022-04-19 | 广东医科大学 | 2，4，7-三取代嘧啶并吲哚化合物抗肿瘤转移作用 |
| CN112851679B (zh) * | 2019-11-28 | 2022-03-25 | 广东医科大学 | 2，4，7-三取代嘧啶并吲哚化合物抗肿瘤作用 |
| AU2020409437A1 (en) * | 2019-12-18 | 2022-07-14 | Universite De Montreal | Modulators of Cullin 3 adaptor KBTBD4 as anti-cancer compounds |
| CN113350356B (zh) * | 2021-05-26 | 2022-12-27 | 广东湛江海洋医药研究院 | 2,4,7-三取代嘧啶并吲哚化合物抗肿瘤耐药作用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5858782A (en) * | 1995-11-13 | 1999-01-12 | Regents Of The University Of Michigan | Functional human hematopoietic cells |
| EP1442039A1 (en) | 2001-10-31 | 2004-08-04 | Bayer HealthCare AG | Pyrimido (4,5-b) indole derivatives |
| US20090099165A1 (en) | 2003-10-14 | 2009-04-16 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Protein Kinase Inhibitors |
| US20090029982A1 (en) | 2005-04-28 | 2009-01-29 | Supergen, Inc. | Protein kinase inhibitors |
| KR20080105555A (ko) | 2007-05-31 | 2008-12-04 | 인하대학교 산학협력단 | 중간엽 골수세포를 이용한 이식편대숙주질환 치료제 및치료방법 |
| EP1795588A1 (en) | 2005-12-07 | 2007-06-13 | Cellerix, S.L. | Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease |
| WO2008055233A1 (en) | 2006-10-31 | 2008-05-08 | Supergen, Inc. | Protein kinase inhibitors |
| EP2121692B1 (en) | 2006-12-22 | 2013-04-10 | Incyte Corporation | Substituted heterocycles as janus kinase inhibitors |
| EP2170886A1 (en) | 2007-07-02 | 2010-04-07 | Cancer Research Technology Limited | 9h-pyrimido[4,5-b]indoles, 9h-pyrido[4',3':4,5]pyrrolo[2,3-d]pyridines, and 9h-1,3,6,9-tetraaza-fluorenes as chk1 kinase function inhibitors |
| US7960400B2 (en) | 2007-08-27 | 2011-06-14 | Duquesne University Of The Holy Ghost | Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof |
| WO2011056739A1 (en) | 2009-11-03 | 2011-05-12 | Glaxosmithkline Llc | Compounds and methods |
| AU2015271985A1 (en) * | 2010-07-13 | 2016-01-21 | Anthrogenesis Corporation | Methods of generating natural killer cells |
| CA2858069C (en) * | 2011-12-08 | 2020-02-11 | Novartis Ag | Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells |
| PT2807165T (pt) | 2012-01-27 | 2019-07-12 | Univ Montreal | Derivados de pirimido[4,5-b]indole e sua utilização na expansão de células estaminais hematopoiéticas |
| JP6460991B2 (ja) | 2012-09-12 | 2019-01-30 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | 抗菌剤として使用するための三環式ジャイレース阻害剤 |
| CA2946446C (en) | 2014-04-22 | 2020-11-03 | Universite De Montreal | Pyrido-pyrrolo-pyrimidine and pyrido-indole compounds, pharmaceutical compositions containing same and their use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cells |
| NZ733213A (en) | 2014-12-31 | 2022-10-28 | Celularity Inc | Natural killer cells and uses thereof |
| MY201637A (en) * | 2015-10-15 | 2024-03-06 | Celularity Inc | Natural killer cells and ilc3 cells and uses thereof |
| WO2017120597A1 (en) | 2016-01-07 | 2017-07-13 | Ripple Foods, Pbc | Product analogs or components of such analogs and processes for making same |
| CA3024273A1 (en) | 2016-06-01 | 2017-12-07 | Universite De Montreal | Selection of human hematopoetic stem cells using epcr |
-
2019
- 2019-02-20 US US16/970,473 patent/US12011460B2/en active Active
- 2019-02-20 CA CA3091865A patent/CA3091865A1/en active Pending
- 2019-02-20 JP JP2020566867A patent/JP7467358B2/ja active Active
- 2019-02-20 WO PCT/CA2019/050208 patent/WO2019161494A1/en not_active Ceased
- 2019-02-20 CN CN201980022329.9A patent/CN112135618A/zh active Pending
- 2019-02-20 EP EP19757891.7A patent/EP3755355A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021521262A5 (https=) | ||
| JP2008517948A5 (https=) | ||
| JP6920644B2 (ja) | 幹細胞の免疫制御作用を調節する方法 | |
| JP2023171766A5 (https=) | ||
| RU2422513C2 (ru) | Способы экспансии популяций миелоидных клеток и их использование | |
| Hagen et al. | Inflammation and the alteration of B-cell physiology in aging | |
| Ueda et al. | IL-1R type I-dependent hemopoietic stem cell proliferation is necessary for inflammatory granulopoiesis and reactive neutrophilia | |
| CN1228443C (zh) | 人胚胎干细胞的造血分化 | |
| Becknell et al. | Interleukin-2, interleukin-15, and their roles in human natural killer cells | |
| JP2015504902A5 (https=) | ||
| EP2836214B1 (en) | Bruton's tyrosine kinase inhibitors for hematopoietic mobilization | |
| CN104066837A (zh) | 增强的干细胞组合物 | |
| US11696928B2 (en) | Compounds and use thereof in the expansion of stem cells and/or progenitor cells | |
| EP2893002A1 (en) | Methods of expanding and assessing b cells and using expanded b cells to treat disease | |
| JP7467358B2 (ja) | 免疫応答を媒介するｉｎ ｖｉｖｏでのＮＫ細胞およびＤＣ細胞の拡大 | |
| WO2015057992A1 (en) | Btk inhibitors for hematopoietic mobilization | |
| Aljagthmi et al. | Hematopoietic stem cells: Understanding the mechanisms to unleash the therapeutic potential of hematopoietic stem cell transplantation | |
| CN109843304A (zh) | 使用自然杀伤细胞治疗急性髓性白血病和多发性骨髓瘤的方法 | |
| CN101313061A (zh) | 扩增双阴性t细胞的方法 | |
| JPWO2019161494A5 (https=) | ||
| JP7621656B2 (ja) | 樹状細胞分化誘導培地、及び樹状細胞集団の製造方法 | |
| US20220273716A1 (en) | Populations of natural killer cells comprising a cd38 chimeric antigen receptor | |
| Deng et al. | Advances in hematopoietic stem cells ex vivo expansion associated with bone marrow niche | |
| US20240226150A9 (en) | Preparation method of citrullinated vimentin antigen-specific immune tolerogenic dendritic cells, and uses thereof | |
| JPWO2023120673A5 (https=) |